Related Experiment Video
Updated: Apr 27, 2026

04:04
Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection
Published on: August 15, 2025
676
Temporal bone carcinoma. Current diagnostic, therapeutic, and prognostic concepts
M Lionello1, P Stritoni, M C Facciolo
1Department of Neurosciences, Otolaryngology Section, University of Padova, Padova, Italy.
Journal of Surgical Oncology
|June 26, 2014
Summary
Temporal bone carcinoma, an aggressive malignancy, presents diagnostic and treatment challenges due to its rarity and lack of a standard staging system. This review analyzes current approaches to staging, treatment, and prognosis for this rare cancer.
Area of Science:
- Oncology
- Otolaryngology
- Surgical Pathology
Background:
- Temporal bone carcinoma is a rare and aggressive malignancy.
- Low incidence and lack of a standardized staging system hinder comparative studies and treatment consensus.
- Effective management requires understanding staging, treatment options, and prognostic factors.
Purpose of the Study:
- To review and synthesize current knowledge on temporal bone carcinoma since 1995.
- To evaluate rational preoperative staging and assessment strategies.
- To compare treatment effectiveness based on tumor stage and identify prognostic factors.
Main Methods:
- Comprehensive literature review of studies on temporal bone carcinoma published since 1995.
- Analysis of preoperative staging and assessment techniques.
- Comparative effectiveness analysis of various treatment modalities across different tumor stages.
- Identification and summary of key actuarial prognostic factors.
Main Results:
- Current literature highlights challenges in diagnosing and staging temporal bone carcinoma due to its rarity.
- Treatment effectiveness varies significantly with tumor stage, necessitating stage-specific approaches.
- Several actuarial factors have been identified as significant predictors of patient outcomes.
Conclusions:
- Standardized staging and further research are crucial for improving outcomes in temporal bone carcinoma.
- Tailoring treatment based on tumor stage and prognostic factors is essential for optimizing patient management.
- This review provides a framework for understanding current best practices and future research directions.
